Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM)

Lexaria Bioscience

Lexaria Bioscience Corp. (CSE;LXX) hit a major milestone this week with their patented DehydraTECHTM technology. An IC50 in vitro study was completed with COVID-19 SARS-CoV-2 antivirals Remdesivir and Ebastine and concluded that their formulation and processing methodology “did not negate the known efficacy of those compounds.” read more

Lucky Minerals Extends Wayka Alteration Zone 500 Meters to the South and Samples Up to 4.15 g/t Gold

LKY.V, Lucky Minerals, gold, Ecuador

Lucky Minerals Inc. (TSXV:LKY)(OTC PINK:LKMNF)(FRA:LKY) (‘Lucky‘ or the ‘Company‘) is pleased to announce it has received sample assay results from its ongoing work at the Wayka epithermal gold discovery at its 100% owned Fortuna Property (‘Fortuna’). Fortuna comprises approximately 55,000 hectares in a known mineralized zone in southern Ecuador. read more